Call Options

17 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$110.76 - $143.18 $299,052 - $386,586
-2,700 Reduced 96.43%
100 $11,000
Q2 2023

Aug 14, 2023

BUY
$126.43 - $145.6 $126,430 - $145,600
1,000 Added 55.56%
2,800 $407,000
Q1 2023

May 15, 2023

BUY
$121.91 - $130.94 $219,438 - $235,692
1,800 New
1,800 $232,000
Q3 2022

Nov 14, 2022

SELL
$101.65 - $119.27 $10,165 - $11,927
-100 Reduced 50.0%
100 $10,000
Q2 2022

Aug 15, 2022

BUY
$102.23 - $133.85 $20,446 - $26,770
200 New
200 $21,000
Q4 2021

Feb 14, 2022

SELL
$115.43 - $146.63 $4.04 Million - $5.13 Million
-35,000 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $4.04 Million - $5.13 Million
35,000 New
35,000 $4.45 Million
Q3 2021

Nov 15, 2021

SELL
$136.35 - $158.76 $27,270 - $31,752
-200 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$152.95 - $173.41 $30,589 - $34,682
200 New
200 $32,000
Q1 2021

May 14, 2021

SELL
$148.16 - $159.71 $9.13 Million - $9.84 Million
-61,600 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$148.16 - $159.71 $8.5 Million - $9.17 Million
57,400 Added 1366.67%
61,600 $9.86 Million
Q4 2020

Feb 16, 2021

BUY
$128.25 - $151.41 $538,650 - $635,922
4,200 New
4,200 $647,000
Q4 2020

Feb 16, 2021

SELL
$128.25 - $151.41 $6.91 Million - $8.16 Million
-53,900 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$113.59 - $141.68 $2.66 Million - $3.32 Million
23,400 Added 76.72%
53,900 $7.34 Million
Q2 2020

Aug 14, 2020

BUY
$87.02 - $133.4 $1.9 Million - $2.91 Million
21,800 Added 250.57%
30,500 $3.64 Million
Q1 2020

May 15, 2020

SELL
$78.28 - $155.73 $6.21 Million - $12.3 Million
-79,300 Reduced 90.11%
8,700 $878,000
Q3 2017

Nov 14, 2017

BUY
$106.92 - $117.79 $9.41 Million - $10.4 Million
88,000
88,000 $10.3 Million

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.2B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.